Abstract
The Zollinger‐Ellison syndrome with its main symptom of massive gastric hypersecretion presents problems with both the medical and surgical approaches to treatment. Successful medical treatment depends on a lifelong commitment to rigid medication schedules requiring careful ongoing supervision and is subject to pitfalls of compliance, drug side effects, drug resistance, and complications of persistent tumor growth. Surgical therapy carries risks of operative mortality and complications. If a low operative mortality can be maintained and the nutritional results after total gastrectomy are good, then it is the authors' opinion that the permanent relief from dangers of hypersecretion afforded by total gastrectomy makes surgery a worthwhile approach. Based on our operative experience in 34 patients and interpretation of the experience of others, we believe that resection of all tumor that can be resected, combined with total gastrectomy, is safe and dependable. The results compare well with those of long‐term medical management.
Original language | English (US) |
---|---|
Pages (from-to) | 91-97 |
Number of pages | 7 |
Journal | Seminars in Surgical Oncology |
Volume | 6 |
Issue number | 2 |
DOIs | |
State | Published - 1990 |
Externally published | Yes |
Keywords
- Zollinger‐Ellison syndrome
- gastric hypersecretion
- medical vs. surgical treatment
- operative technique and exploration
- secretin provocation test
ASJC Scopus subject areas
- Surgery
- Oncology